{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:04:17Z","timestamp":1774789457341,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.081","type":"journal-article","created":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:33Z","timestamp":1325376033000},"page":"1305-1312","source":"Crossref","is-referenced-by-count":71,"title":["Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles"],"prefix":"10.1016","volume":"30","author":[{"given":"Yu-Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-I","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tze-Jiun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Chieh","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Kuang","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae-Ning","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bor-Luen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.12.081_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.12.081_bib0010","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1128\/JVI.73.12.9969-9975.1999","article-title":"Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998","volume":"73","author":"Brown","year":"1999","journal-title":"J Virol"},{"issue":"December (2\u20133)","key":"10.1016\/j.vaccine.2011.12.081_bib0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-1702(95)00087-9","article-title":"Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus","volume":"39","author":"Brown","year":"1995","journal-title":"Virus Res"},{"issue":"June (5)","key":"10.1016\/j.vaccine.2011.12.081_bib0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0092-8674(86)90790-7","article-title":"A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein","volume":"45","author":"Toyoda","year":"1986","journal-title":"Cell"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.12.081_bib0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0042-6822(88)90172-9","article-title":"Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor","volume":"166","author":"Ypma-Wong","year":"1988","journal-title":"Virology"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.12.081_bib0030","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/JVI.01019-09","article-title":"Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene","volume":"84","author":"Tee","year":"2010","journal-title":"J Virol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.12.081_bib0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3201\/eid0904.020395","article-title":"Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes","volume":"9","author":"Cardosa","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.12.081_bib0040","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S1474-4422(08)70207-2","article-title":"Enterovirus 71 infection: a new threat to global public health?","volume":"7","author":"Qiu","year":"2008","journal-title":"Lancet Neurol"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2011.12.081_bib0045","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/591462","article-title":"Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis","volume":"198","author":"Wang","year":"2008","journal-title":"J Infect Dis"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.12.081_bib0050","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1086\/592988","article-title":"Enterovirus-associated encephalitis in the California encephalitis project, 1998\u20132005","volume":"198","author":"Fowlkes","year":"2008","journal-title":"J Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.12.081_bib0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3201\/eid0903.020285","article-title":"Enterovirus 71 outbreaks, Taiwan: occurrence and recognition","volume":"9","author":"Lin","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.12.081_bib0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.291.2.222","article-title":"Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan","volume":"291","author":"Chang","year":"2004","journal-title":"JAMA"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.12.081_bib0065","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/376998","article-title":"Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema","volume":"188","author":"Wang","year":"2003","journal-title":"J Infect Dis"},{"issue":"December (5\u20136)","key":"10.1016\/j.vaccine.2011.12.081_bib0070","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2001","journal-title":"Vaccine"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2011.12.081_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<228::AID-JMV9>3.0.CO;2-R","article-title":"Expression of capsid [correction of caspid] protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection","volume":"61","author":"Shih","year":"2000","journal-title":"J Med Virol"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.12.081_bib0080","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2008.03.041","article-title":"Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection","volume":"26","author":"Chen","year":"2008","journal-title":"Vaccine"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2011.12.081_bib0085","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1016\/j.vaccine.2005.12.047","article-title":"Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71","volume":"24","author":"Chen","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.081_bib0090","doi-asserted-by":"crossref","unstructured":"Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 2010;84(January (1)):661\u20135.","DOI":"10.1128\/JVI.00999-09"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2011.12.081_bib0095","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3748\/wjg.v12.i6.921","article-title":"Expression, purification and characterization of enterovirus-71 virus-like particles","volume":"12","author":"Chung","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"March (15)","key":"10.1016\/j.vaccine.2011.12.081_bib0100","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2011.12.081_bib0105","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0264-410X(02)00182-2","article-title":"Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate","volume":"20","author":"Lin","year":"2002","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.12.081_bib0110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/14712598.7.7.997","article-title":"Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer","volume":"7","author":"Ramqvist","year":"2007","journal-title":"Expert Opin Biol Ther"},{"issue":"March (3):","key":"10.1016\/j.vaccine.2011.12.081_bib0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1517\/14712591003601944","article-title":"HPV vaccine: cervarix","volume":"10","author":"Szarewski","year":"2010","journal-title":"Expert Opin Biol Ther"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.12.081_bib0120","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1586\/erv.09.81","article-title":"Virus-like particle vaccines and adjuvants: the HPV paradigm","volume":"8","author":"Buonaguro","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.12.081_bib0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymeth.2006.05.024","article-title":"Virus-like particles: designing an effective AIDS vaccine","volume":"40","author":"Young","year":"2006","journal-title":"Methods"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.12.081_bib0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.clpt.6100055","article-title":"GARDASIL: prophylactic human papillomavirus vaccine development \u2013 from bench top to bed-side","volume":"81","author":"Shi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2011.12.081_bib0135","doi-asserted-by":"crossref","first-page":"e21757","DOI":"10.1371\/journal.pone.0021757","article-title":"Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice","volume":"6","author":"Meng","year":"2011","journal-title":"PLoS One"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.12.081_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.12.081_bib0145","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood-2009-08-238543","article-title":"Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists","volume":"115","author":"Rajagopal","year":"2010","journal-title":"Blood"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.12.081_bib0150","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/JVI.01019-09","article-title":"Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene","volume":"84","author":"Tee","year":"2010","journal-title":"J Virol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.12.081_bib0155","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2011.12.081_bib0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/hv.3.4.4058","article-title":"Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions","volume":"3","author":"Smith","year":"2007","journal-title":"Hum Vaccin"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.12.081_bib0165","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/JVI.70.5.3298-3301.1996","article-title":"Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition","volume":"70","author":"Roden","year":"1996","journal-title":"J Virol"},{"issue":"February (13\u201314)","key":"10.1016\/j.vaccine.2011.12.081_bib0170","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0264-410X(00)00370-4","article-title":"Immunological analyses of human papillomavirus capsids","volume":"19","author":"Giroglou","year":"2001","journal-title":"Vaccine"},{"issue":"February (6)","key":"10.1016\/j.vaccine.2011.12.081_bib0175","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.10153","article-title":"Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer","volume":"97","author":"Combita","year":"2002","journal-title":"Int J Cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T22:30:21Z","timestamp":1593469821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11020305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11020305"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}